11-557617-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_173573.3(LMNTD2):c.579G>T(p.Met193Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000779 in 1,613,232 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173573.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMNTD2 | ENST00000329451.8 | c.579G>T | p.Met193Ile | missense_variant | Exon 6 of 14 | 1 | NM_173573.3 | ENSP00000331167.3 | ||
LMNTD2 | ENST00000441853.5 | c.600G>T | p.Met200Ile | missense_variant | Exon 7 of 9 | 3 | ENSP00000393529.1 | |||
LMNTD2 | ENST00000486629.1 | c.609G>T | p.Met203Ile | missense_variant | Exon 6 of 7 | 5 | ENSP00000435529.1 | |||
LMNTD2-AS1 | ENST00000527620.5 | n.23C>A | non_coding_transcript_exon_variant | Exon 1 of 2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000322 AC: 49AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000260 AC: 65AN: 250348Hom.: 0 AF XY: 0.000236 AC XY: 32AN XY: 135618
GnomAD4 exome AF: 0.000826 AC: 1207AN: 1460934Hom.: 2 Cov.: 36 AF XY: 0.000795 AC XY: 578AN XY: 726748
GnomAD4 genome AF: 0.000322 AC: 49AN: 152298Hom.: 0 Cov.: 33 AF XY: 0.000376 AC XY: 28AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.579G>T (p.M193I) alteration is located in exon 6 (coding exon 6) of the LMNTD2 gene. This alteration results from a G to T substitution at nucleotide position 579, causing the methionine (M) at amino acid position 193 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at